PHARMEXCIL engages in high-level meetings to discuss roadmap for India’s generic pharma exports
The leadership of Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) held a series of high-level meetings with senior…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Nipun Jain
Pharma industry requests centralised KYC depository system at ports to avoid shipping delays
Resubmission of KYC at a new port each time is duplication work for exporters, customs officials and all other teams, point out…
DoP issues revised public procurement guidelines
The objective is to further encourage the 'Make in India' and promote the manufacturing and production of goods and services in…
Pharma industry urges government to extend MEIS scheme till March 2021
Since April 2020, the Indian pharma industry is facing a challenge in availing the MEIS benefits
Pharma industry seeks support from the government on MEIS
MEIS will be available to exporters only up to December 31, 2020, it is getting replaced with RoDTEP
Container shortage affects pharma exports, industry seeks solution
Due to the shortages of containers, exporters are facing 50-60 per cent hike in the freight charges
Pharma industry appreciates modification in PLI scheme, seek more support
The industry also raises concerns related to brownfield investments, protection of indigenous manufacturing
Pharma industry lauds RBI’s decision to discontinue automatic caution listing
RBI will continue with caution-listing based on case-specific recommendations of the AD bank
DGFT extends implementation date of track and trace for parent-child packaging to April 1, 2021
As per an earlier directive, it was scheduled for implementation from October 1, 2020
Industry urges DoP to expedite implementation of PTUAS
Recommends changes in the existing criteria of PTUAS